Lilly to participate in Leerink Partners Global Healthcare Conference
Eli Lilly (NYSE: LLY) has announced its participation in the upcoming Leerink Partners Global Healthcare Conference scheduled for March 10, 2025. The company's executive vice president and CFO, Lucas Montarce, will engage in a fireside chat at 9:20 a.m. Eastern time.
Investors and interested parties can access a live audio webcast of the presentation through Lilly's investor website in the 'Webcasts & Presentations' section. The recording will remain available for approximately 90 days following the event.
Eli Lilly (NYSE: LLY) ha annunciato la sua partecipazione alla prossima Conferenza Globale sulla Salute di Leerink Partners, programmata per il 10 marzo 2025. Il vicepresidente esecutivo e CFO dell'azienda, Lucas Montarce, parteciperà a una chiacchierata informale alle 9:20 ora orientale.
Gli investitori e le parti interessate possono accedere a un webcast audio in diretta della presentazione attraverso il sito web per investitori di Lilly nella sezione 'Webcast e Presentazioni'. La registrazione rimarrà disponibile per circa 90 giorni dopo l'evento.
Eli Lilly (NYSE: LLY) ha anunciado su participación en la próxima Conferencia Global de Salud de Leerink Partners, programada para el 10 de marzo de 2025. El vicepresidente ejecutivo y CFO de la compañía, Lucas Montarce, participará en una charla informal a las 9:20 a.m. hora del Este.
Los inversores y partes interesadas pueden acceder a un webcast de audio en vivo de la presentación a través del sitio web de inversores de Lilly en la sección 'Webcasts y Presentaciones'. La grabación estará disponible durante aproximadamente 90 días después del evento.
엘리 릴리 (NYSE: LLY)는 2025년 3월 10일로 예정된 리어링크 파트너스 글로벌 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 회사의 부회장 겸 CFO인 루카스 몬타르체가 동부 표준시 기준 오전 9시 20분에 화상 대화에 참여할 예정입니다.
투자자와 관심 있는 분들은 릴리의 투자자 웹사이트 '웹캐스트 및 프레젠테이션' 섹션을 통해 실시간 오디오 웹캐스트에 접근할 수 있습니다. 녹화는 이벤트 후 약 90일 동안 제공됩니다.
Eli Lilly (NYSE: LLY) a annoncé sa participation à la prochaine Conférence Mondiale sur la Santé de Leerink Partners prévue pour le 10 mars 2025. Le vice-président exécutif et CFO de l'entreprise, Lucas Montarce, participera à une discussion informelle à 9h20, heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à un webcast audio en direct de la présentation via le site des investisseurs de Lilly dans la section 'Webcasts et Présentations'. L'enregistrement sera disponible pendant environ 90 jours après l'événement.
Eli Lilly (NYSE: LLY) hat seine Teilnahme an der bevorstehenden Leerink Partners Global Healthcare Conference, die für den 10. März 2025 geplant ist, bekannt gegeben. Der Executive Vice President und CFO des Unternehmens, Lucas Montarce, wird um 9:20 Uhr Eastern Time an einem informellen Gespräch teilnehmen.
Investoren und Interessierte können über die Investoren-Website von Lilly im Abschnitt 'Webcasts & Präsentationen' auf einen Live-Audio-Webcast der Präsentation zugreifen. Die Aufzeichnung bleibt etwa 90 Tage nach der Veranstaltung verfügbar.
- None.
- None.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-leerink-partners-global-healthcare-conference-302387950.html
SOURCE Eli Lilly and Company
FAQ
When is Eli Lilly (LLY) presenting at the Leerink Partners Conference 2025?
Who will represent LLY at the Leerink Partners Healthcare Conference 2025?
How can investors watch LLY's presentation at the Leerink Conference?
How long will LLY's Leerink Conference presentation recording be available?
